TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 DKK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover |
241
|
169
|
302 |
Financial expenses |
0
|
42
|
22 |
Earnings before taxes |
13
|
1,430
|
79 |
EBITDA |
-22
|
11
|
73 |
Total assets |
4,299
|
4,730
|
3,550 |
Current assets |
4,033
|
4,436
|
3,196 |
Current liabilities |
54
|
47
|
79 |
Equity capital |
4,200
|
4,623
|
3,373 |
- share capital |
63
|
70
|
73 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency |
97.7%
![]() |
97.7%
|
95.0% |
Turnover per employee |
241
|
169
|
302 |
Profit as a percentage of turnover |
5.4%
|
846.2%
|
26.2% |
Return on assets (ROA) |
0.3%
|
31.1%
|
2.8% |
Current ratio |
7468.5%
|
9438.3%
|
4045.6% |
Return on equity (ROE) |
0.3%
|
30.9%
|
2.3% |
Change turnover |
88
|
-117
|
-232 |
Change turnover % |
57%
|
-41%
|
-43% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.